Cagri + Sema (5mg + 5mg)

Research Peptide Combination

A lyophilized peptide vial containing:

• Cagrilintide – 5mg
• Semaglutide – 5mg

For research use only. Not intended for human use.

Product Highlights

• Lyophilized powder
• Janoshik laboratory verified
• Certificate of Analysis (COA) available
• High-purity research material
• Single vial containing both peptides

Product Specifications

What Is Cagri+Sema?

Cagri+Sema combines two research peptides in one vial:

• Cagrilintide, a long-acting amylin analogue.
• Semaglutide, a GLP-1 receptor agonist.

Researchers use the combination to study dual metabolic signaling pathways in laboratory settings.

Quality Testing

Every batch is independently tested by Janoshik Laboratory using:

• HPLC analysis
• Mass spectrometry

Each batch includes a Certificate of Analysis verifying purity and identity.

Storage Instructions

Before Reconstitution

• Store at −20°C.
• Protect from moisture.
• Avoid repeated freeze-thaw cycles.

After Reconstitution

• Store at 2–8°C.
• Use within 28 days.
• Do not refreeze.

Research Applications

Researchers study this combination because:

• Cagrilintide acts on amylin receptors.
• Semaglutide acts on GLP-1 receptors.
• Together they allow investigation of dual-pathway metabolic signaling.

Disclaimer

This product is sold exclusively for laboratory and research use. It is not approved for human or animal administration and is not intended for diagnosis, treatment, cure, or prevention of any disease.